Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

BACKGROUND: Adenocarcinoma originating from the digestive system is a major contributor to cancer-related deaths worldwide. Tumor recurrence, advanced local growth and metastasis are key factors that frequently prevent these tumors from curative surgical treatment. Preclinical research has demonstra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393860/
https://ncbi.nlm.nih.gov/pubmed/25879229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1241-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados